305
Views
7
CrossRef citations to date
0
Altmetric
Review

Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies

, , &
Pages 1113-1123 | Received 02 Apr 2016, Accepted 27 May 2016, Published online: 09 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now

Articles from other publishers (6)

Chiara Capelli, Carolina Cuofano, Chiara Pavoni, Simona Frigerio, Daniela Lisini, Sara Nava, Michele Quaroni, Valentina Colombo, Francesco Galli, Svetlana Bezukladova, Paola Panina-Bordignon, Giuseppe Gaipa, Patrizia Comoli, Giulio Cossu, Gianvito Martino, Andrea Biondi, Martino Introna & Josée Golay. (2023) Potency assays and biomarkers for cell-based advanced therapy medicinal products. Frontiers in Immunology 14.
Crossref
Liam J. O’Brien, Camille Guillerey & Kristen J. Radford. (2019) Can Dendritic Cell Vaccination Prevent Leukemia Relapse?. Cancers 11:6, pages 875.
Crossref
Domenico Galati & Serena Zanotta. (2018) Empowering dendritic cell cancer vaccination: the role of combinatorial strategies. Cytotherapy 20:11, pages 1309-1323.
Crossref
Paul M. Armistead & Jonathan S. Serody. 2018. Immunotherapy in Translational Cancer Research. Immunotherapy in Translational Cancer Research 54 71 .
Haneen Shalabi, Hahn Khuu, Terry J. Fry & Nirali N. Shah. 2018. Novel Designs of Early Phase Trials for Cancer Therapeutics. Novel Designs of Early Phase Trials for Cancer Therapeutics 175 191 .
Matthew Weinstock, Jacalyn Rosenblatt & David Avigan. (2017) Dendritic Cell Therapies for Hematologic Malignancies. Molecular Therapy - Methods & Clinical Development 5, pages 66-75.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.